A new evidence-based guideline on how to identify and treat patients with nonvalvular atrial fibrillation to prevent cardioembolic stroke from the American Academy of Neurology suggests when to...
SAN DIEGO – After 6 months, Medtronic’s Reveal XT implant picked up atrial fibrillation in 8.6% of cryptogenic stroke patients. Standard monitoring found it in 1.4%, according to company data...
SAN DIEGO – Medtronic’s Reveal XT heart monitor implant detected atrial fibrillation missed by older techniques in a randomized trial.
The company’s North American and European <link...
Medicare will begin covering cardiac rehabilitation for patients with stable, chronic heart failure with a left ventricular ejection fraction of 35% or less.
The Centers for Medicare & Medicaid...
Just as spring training has begun, the National Institutes of Health has withdrawn funding for an important clinical trial, "Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes...
SNOWMASS, COLO. – Recent large studies validate and fine-tune the 2013 American Heart Association/American College of Cardiology guidelines on diet and lifestyle management to reduce cardiovascular...
Among younger patients with treatment-naive paroxysmal atrial fibrillation, radiofrequency ablation modestly lowered the rate of recurrent atrial tachyarrhythmia during 2 years of follow-up, compared...
SNOWMASS, COLO. – Detection of myocardial midwall fibrosis via cardiovascular magnetic resonance in patients with nonischemic dilated cardiomyopathy provides prognostic information independent of...
Noninvasive cardiovascular imaging in U.S. medical practice today raises two policy challenges, according to a statement released on Feb. 17 by the American College of Cardiology and 13 collaborating...
As expected, the Food and Drug Administration has declined to approve the oral anticoagulant rivaroxaban for treating acute coronary syndromes.
The manufacturer of the factor Xa inhibitor, Janssen...
